Related Experiment Video
Updated: Aug 14, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on
J E Maynard1, M A Kane, S C Hadler
1Division of Viral Diseases, Centers for Disease Control, Atlanta, Georgia 30333.
Abstract:
Hepatitis B is a disease that affects people throughout the world, and over 200 million are persistent carriers of the hepatitis B virus (HBV). The chronic sequelae of this infection include chronic active hepatitis, cirrhosis, and primary hepatocellular carcinoma. The development of safe and highly effective hepatitis B vaccines now provides the means by which HBV infection, including the HBV chronic carrier state, can be prevented and the related mortality significantly reduced. The cost of these vaccines has significantly decreased and will soon approach levels at which the cost-effectiveness (cost per death prevented) of hepatitis B vaccine will be similar to that of other childhood vaccines. Integration of hepatitis B vaccine into the Expanded Programme on Immunization for mass vaccination of infants in areas where HBV infection is endemic and morbidity is high would be the most effective means of providing the coverage necessary for effective control and prevention.
Related Concept Videos
Vaccinations
Microorganisms in Medicine and Therapeutics
Vaccines
Smallpox
Hepatitis
Viral Hepatitis I: Introduction

